Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/35573
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSpinou, Arietta-
dc.contributor.authorLee, Annemarie L-
dc.contributor.authorO'Neil, Brenda-
dc.contributor.authorOliveira, Ana-
dc.contributor.authorShteinberg, Michal-
dc.contributor.authorHerrero-Cortina, Beatriz-
dc.date2024-
dc.date.accessioned2024-12-02T00:45:15Z-
dc.date.available2024-12-02T00:45:15Z-
dc.date.issued2024-10-
dc.identifier.citationEuropean Respiratory Review : an Official Journal of the European Respiratory Society 2024-10; 33(174)en_US
dc.identifier.issn1600-0617-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/35573-
dc.description.abstractBronchiectasis is a chronic lung condition which is characterised by recurrent chest infections, chronic sputum production and cough, and limited exercise tolerance. While bronchiectasis may be caused by various aetiologies, these features are shared by most patients with bronchiectasis regardless of the cause. This review consolidates the existing evidence on patient-managed interventions for adults with bronchiectasis, while also outlining areas for future research. Airway clearance techniques and hyperosmolar agents are key components of the bronchiectasis management and consistently recommended for clinical implementation. Questions around their prescription, such as optimal sequence of delivery, are still to be answered. Pulmonary rehabilitation and exercise are also recommended for patients with bronchiectasis. Relatively strong evidence underpins this recommendation during a clinically stable stage of the disease, although the role of pulmonary rehabilitation following an exacerbation is still unclear. Additionally, self-management programmes feature prominently in bronchiectasis treatment, yet the lack of consensus regarding their definition and outcomes presents hurdles to establishing a cohesive evidence base. Moreover, cough, a cardinal symptom of bronchiectasis, warrants closer examination. Although managing cough in bronchiectasis may initially appear risky, further research is necessary to ascertain whether strategies employed in other respiratory conditions can be safely and effectively adapted to bronchiectasis, particularly through identifying patient responder populations and criteria where cough may not enhance airway clearance efficacy and its control is needed. Overall, there is a growing recognition of the importance of patient-managed interventions in the bronchiectasis management. Efforts to improve research methodologies and increase research funding are needed to further advance our understanding of these interventions, and their role in optimising patient care and outcomes.en_US
dc.language.isoeng-
dc.titlePatient-managed interventions for adults with bronchiectasis: evidence, challenges and prospects.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleEuropean Respiratory Review : an Official Journal of the European Respiratory Societyen_US
dc.identifier.affiliationSchool of Life Course and Population Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.;King's Centre for Lung Health, King's College London, London, UK.en_US
dc.identifier.affiliationInstitute for Breathing and Sleepen_US
dc.identifier.affiliationSchool of Health Sciences, Ulster University, Coleraine, UK.en_US
dc.identifier.affiliationSchool of Rehabilitation Sciences, Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada.;West Park Healthcare Centre, Toronto, ON, Canada.;Lab3R - Respiratory Research and Rehabilitation Laboratory, School of Health Sciences, University of Aveiro (ESSUA), Aveiro, Portugal.;iBiMED - Institute of Biomedicine, Department of Medical Sciences, University of Aveiro, Aveiro, Portugal.en_US
dc.identifier.affiliationPulmonology Institute and Cystic Fibrosis Center, Carmel Medical Center and the Technion Israel Institute of Technology, the B. Rappaport Faculty of Medicine, Haifa, Israel.en_US
dc.identifier.affiliationPrecision Medicine in Respiratory Diseases Group, Instituto de Investigación Sanitaria (IIS) Aragón, Zaragoza, Spain.;Universidad San Jorge, Zaragoza, Spain.en_US
dc.identifier.doi10.1183/16000617.0087-2024en_US
dc.type.contentTexten_US
dc.identifier.orcid0000-0002-3442-4739en_US
dc.identifier.orcid0000-0002-8631-0135en_US
dc.identifier.orcid0000-0003-4516-6904en_US
dc.identifier.orcid0000-0002-0432-3398en_US
dc.identifier.orcid0000-0002-4749-0444en_US
dc.identifier.pubmedid39477356-
dc.description.volume33-
dc.description.issue174-
dc.subject.meshtermssecondaryBronchiectasis/therapy-
dc.subject.meshtermssecondaryBronchiectasis/physiopathology-
dc.subject.meshtermssecondaryBronchiectasis/diagnosis-
dc.subject.meshtermssecondaryLung/physiopathology-
dc.subject.meshtermssecondaryRespiratory Therapy/methods-
item.fulltextNo Fulltext-
item.openairetypeJournal Article-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.languageiso639-1en-
item.cerifentitytypePublications-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

8
checked on Dec 17, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.